On February 13th, the Amaury Sports Organization (ASO) barred Team Astana from competing in any race or event organized by the ASO in 2008. The ASO owns premiere cycling events like Paris-Nice, Paris-Roubaix, Paris-Tours, and the famed Tour de France.

The ASO cited the doping scandals of last year’s Tour de France as justification.
There can be no comparison between the Astana team of 2007 and the new Astana. The entire organizational structure has been rebuilt under the direction of the team’s new General Manager, Johan Bruyneel, who has thoroughly cleaned house. What’s more, Astana has adopted the rigorous doping controls developed by anti-doping expert Dr. Rasmus Damsgaard, and Astana now spends more money on anti-doping controls than any other team in the pro peloton.

“That the happenings of last year…prompted the Tour organizers to leave Astana out of the season’s most important race sounds understandable,” notes Bruyneel. “However, Astana Cycling Team 2008 has nothing to do with the team of last year. We have done everything to change the dynamics of the team. New management, new riders, new philosophy. Only the name of the sponsor remained.”

The ASO has turned a blind eye to Johan’s efforts. By barring the entire team from competing in ASO events, outstanding athletes like Levi Leipheimer, who was not a member of last year’s Astana team and who has never been implicated in any doping affair, are forced to sit on the sidelines while their life’s work passes them by.

“When I saw the Tour de France on TV when I was young,” laments Leipheimer, “I knew that someday I wanted to do that race. I sacrificed my life to participate. After finishing on the podium last year I want to do even better. Now I’m a victim of an illogical decision and have been excluded from the race.”

Be Heard
Help put Levi’s dreams back on track by signing the petition to Let Levi Ride. Petitions will be sent directly to Christian Prudhomme, Director of the ASO, as well as to VS, the official US media partner of the Tour de France.

Go To: http://letleviride.com/